ArticleJournal of translational medicine2024

RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway.

Zhidong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.